The Eternal Optimist – Andrew Plump

SpreadLove In Organizations
SpreadLove In Organizations
The Eternal Optimist - Andrew Plump
/

This episode is in partnership with MIT Sloan Healthcare and BioInnovations Conference, an event that brings the healthcare ecosystem together. We sat with Andy Plump, President of R&D and Board Member at Takeda, and discussed his personal story, his leadership beliefs, and the “Challenges in Scaling Biotech Innovation” the topic of his panel at the conference. Hear his thoughts on the current and next decades of innovation, “will it be the decades of Life Science or Computer Science?” Most importantly, Andy leaves us with a message of hope. Every dark period in history anchored on the triad of war, pandemic, and social injustice has ended with greatness through science… We are on the edge of this, again, now.

“This decade will be remembered for Life Science or Computer Science… The potential is limitless.

MEET OUR GUEST Andrew Plump President of Research & Development and Board Member at Takeda.

Dr. Andrew Plum is the President of Research & Development and a Board Member at Takeda. His career spans nearly 30 years in the pharmaceutical industry and academia.

Andy has been recognized for his contributions to the healthcare industry, education, and the arts. He serves on several non-profit boards including the Board of Trustees for the Boston Symphony Orchestra, the Sarnoff Cardiovascular Research Foundation, the Biomedical Science Careers Program, and as Chairman of the Board of Directors for the PhRMA Foundation.

Prior to Takeda, Andrew served as head of Research & Translational Medicine, deputy to the president of R&D at Sanofi, based in Paris, France. Prior to Sanofi, he served as worldwide cardiovascular research head at Merck.

Andy received his M.D. from the University of California, San Francisco (UCSF), his Ph.D. in cardiovascular genetics, and his B.S. from the Massachusetts Institute of Technology (MIT). He completed a residency in internal medicine and a fellowship in medical genetics at UCSF.

EPISODE TRANSCRIPT: Andrew Plump

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love. I am Naji, your host for this special episode in partnership with MIT Sloan Healthcare and BioInnovations Conference, an event that brings the Healthcare Ecosystem Together. I am joined today Andrew Plump President of Research & Development and Board Member at Takeda. His career spans nearly 30 years in the pharmaceutical industry and academia. Andrew has been recognized for his contributions to…

Work to Make a Difference – Michael Ullmann

SpreadLove In Organizations
SpreadLove In Organizations
Work to Make a Difference - Michael Ullmann
/

Being in healthcare is a privilege and a humbling responsibility; we impact lives. This is what Michael Ullman has done throughout his years at Johnson & Johnson from where he retired recently as Executive VP, General Counsel & Executive Committee Member. Leadership for Mike is grounded in humility, kindness, and optimism, it is above all a responsibility to other people. Hear Mike’s experience leading JNJ to deliver on covid vaccine that saved humanity during the pandemic, and his thoughts on ESG, Health Equity, social responsibility, and how to build high-performing teams to ensure we deliver on our purpose. As leaders, our job is not to be superstars but rather shine through others, through our people’s greatness. Kindness is underused in the world, create a culture that demands it, treat people with respect, trust them, empower them, and help them succeed.

“Kindness is underused. Create a culture that demands it.”

MEET OUR GUEST Michael Ullmann, (Retired) Executive Vice President, General Counsel & Executive Committee Member, Johnson & Johnson

Michael Ullmann retired from Johnson & Johnson earlier this year after over 33 years with the Company.  For the last 11 years, he served as a member of the J&J Executive Committee and the Executive Vice President, General Counsel leading a global organization of over 2,000 employees in 60 countries encompassing Legal, Government Relations & Policy, ESG Strategy, Intellectual Property, Corporate Governance, Data Privacy, Compliance and Security. 

As General Counsel of the world’s largest Life Sciences company, he successfully guided JNJ through high-profile and high-risk situations, while helping to grow the business to annual sales of $94 billion, increase shareholder value and maintain its reputation as one of the most admired companies in the world. 

Mike joined Johnson & Johnson in 1989 as a mergers & acquisitions attorney and held various management positions, including General Counsel of the Worldwide Medical Devices Group, before becoming the company’s General Counsel in 2012. Michael is a member of the Board of Directors of Americares and serves on the Columbia Law School Board of Visitors. 

EPISODE TRANSCRIPT: Michael Ullmann

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love. I am Naji, your host, joined today by Mike Ullmann. Mike retired from Johnson & Johnson earlier this year after over 33 years with the Company.  For the last 11 years, he served as a member of the J&J Executive Committee and the Executive Vice President, General Counsel leading a global organization of over 2,000 employees in 60 countries encompassing Legal, Government Relations & Policy, ESG Strategy, Intellectual Property, Corporate Governance, Data Privacy, Compliance and…

Ask the Big Questions – Melanie Ivarsson

SpreadLove In Organizations
SpreadLove In Organizations
Ask the Big Questions - Melanie Ivarsson
/

In this episode, we chatted with Melanie Ivarsson, Chief Development Officer at Moderna, who led teams in times the world was anxiously waiting for them to deliver us a hope with Covid Vaccine… and they did. How did they achieve this? How do you lead in such unprecedented times? How do you ensure this sense of purpose continues to live today? Hear all about those stories and about Melanie’s biggest leadership learning throughout this once-in-a-lifetime experience: Enable others to be the best they can be, and don’t get in their way.

“Hang on to your true self.”

MEET OUR GUEST Melanie Ivarsson Chief Development Officer at Moderna.

Melanie Ivarsson is Senior Vice President, Chief Development Officer at Moderna, where she leads the Clinical Development Operations department. In this role Dr Ivarsson and her team deliver all clinical programs within the Moderna portfolio.

Melanie has more than 20 years of experience in the pharmaceutical industry. Prior to joining Moderna, she was Head of Global Clinical Operations, at Takeda (following the acquisition of Shire) and spent 9 years at Pfizer in Clinical Development. She also held roles within the early clinical development group at Eli Lilly.

After receiving her PhD from the University of Bristol, she completed postdoctoral research at Lund University and New York University. Dr Ivarsson also holds an Executive MBA from MIT Sloan School of Management.

EPISODE TRANSCRIPT: Melanie Ivarsson

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love. I am Naji, your host today, having the pleasure to be joined by Melanie Ivarsson Chief Development Officer at Moderna. In this role Melanie leads the Clinical Development Operations department and delivers with her team all clinical programs within the Moderna portfolio. Prior to joining Moderna, she was Head of Global Clinical Operations at Takeda and spent 9 years at Pfizer in…